AIMN.US Lee Pharmaceuticals, Inc.

Financial Services Shell Companies USA Stocks
0.0008 USD
Close of Nov 13, 2026
0.0005 6.00
Market cap
USD 264K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is AIMN.US undervalued?

Graham number

The Graham number of Lee Pharmaceuticals, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lee Pharmaceuticals, Inc. fundamental analysis

No fundamental analysis for Lee Pharmaceuticals, Inc. yet.

Lee Pharmaceuticals, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lee Pharmaceuticals, Inc.

Aimwell Partners Inc. develops healthcare intelligence, regulatory technology, and AI-driven verification infrastructure. The company provides source-verified intelligence systems, including regulatory monitoring, clinical intelligence, hallucination containment, and the Federated Health Intelligence Network for the biopharmaceutical and healthcare industries. Aimwell Partners Inc. was incorporated in 2013 and is headquartered in Mobile, Alabama.

Full company profile